Evidence map›Paper›PMID 30410768›Full record

ArticlePharmacology research & perspectives2018

Effects of cardiopulmonary bypass on the disposition of cefazolin in patients undergoing cardiothoracic surgery.

Mizuho Asada, Masashi Nagata, Tomohiro Mizuno, Tokujiro Uchida, Naoki Kurashima, Hiromitsu Takahashi, Koshi Makita, Hirokuni Arai, Hirotoshi Echizen, Masato Yasuhara

Open access · goldAbstract read
In one paragraph

Article in Pharmacology research & perspectives, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Surgical Site Infection in Cardiac Surgery.Journal of clinical medicine · 2022
    Review
  9. Article
  10. Article
  11. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Mizuho AsadaDepartment of Pharmacy Medical Hospital Tokyo Medical and Dental University (TMDU) Tokyo Japan.
Masashi NagataDepartment of Pharmacy Medical Hospital Tokyo Medical and Dental University (TMDU) Tokyo Japan.ORCID 0000-0003-3169-7210
Tomohiro MizunoDepartment of Cardiovascular Surgery Graduate School of Medical and Dental Science Tokyo Medical and Dental University (TMDU) Tokyo Japan.
Tokujiro UchidaDepartment of Anesthesiology Graduate School of Medical and Dental Sciences Tokyo Medical and Dental University (TMDU) Tokyo Japan.
Naoki KurashimaMedical Engineering Center Medical Hospital of Tokyo Medical and Dental University (TMDU) Tokyo Japan.
Hiromitsu TakahashiDepartment of Pharmacy Medical Hospital Tokyo Medical and Dental University (TMDU) Tokyo Japan.
Koshi MakitaDepartment of Anesthesiology Graduate School of Medical and Dental Sciences Tokyo Medical and Dental University (TMDU) Tokyo Japan.
Hirokuni AraiDepartment of Cardiovascular Surgery Graduate School of Medical and Dental Science Tokyo Medical and Dental University (TMDU) Tokyo Japan.
Hirotoshi EchizenDepartment of Pharmacotherapy Meiji Pharmaceutical University Tokyo Japan.
Masato YasuharaDepartment of Pharmacokinetics and Pharmacodynamics Graduate School of Medical and Dental Sciences Tokyo Medical and Dental University (TMDU) Tokyo Japan.
Tokyo Medical and Dental University · JPTokyo Medical and Dental University Hospital · JPMeiji Pharmaceutical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the study was to evaluate the disposition of plasma unbound cefazolin in patients undergoing cardiothoracic surgery with cardiopulmonary bypass (CPB). Adult patients undergoing cardiothoracic surgery with CPB were enrolled in the study. Cefazolin sodium was given intravenously before skin incision (1 g) and at the beginning of CPB (2 g). Thereafter, an additional dose (1 g) was given every 4 hours. Seven to ten blood samples were collected before and during surgery. Plasma total and unbound (ultrafiltrated) cefazolin concentrations were analyzed using an HPLC-UV method. Plasma protein binding was analyzed with the Langmuir model. Twenty-seven patients (aged 70 ± 12 years, body weight 62 ± 12 kg, mean ± SD) with GFR >30 mL min

Indexed as

AdultAgedAged, 80 and overAnti-Bacterial AgentsAntibiotic ProphylaxisCardiopulmonary BypassCefazolinFemaleHumansMaleMiddle AgedProtein BindingSerum Albumin, HumanSurgical Wound InfectionAnti-Bacterial AgentsCefazolinSerum Albumin, Humancardiopulmonary bypasscefazolinplasma protein bindingsurgical site infectionunbound fraction

Identifiers

PMID30410768
PMCPMC6218359
OpenAlexW2899863914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.